Bactericidal action of ampicillin/sulbactam against intracellular mycobacteria

International Journal of Antimicrobial Agents

Volumn 13, Issue 2, 1999, Pages 133-135

  Prabhakaran, K ^a   Harris, E B ^a   Randhawa, B ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Lactamase; Ampicillin sulbactam; Macrophages; Mycobacteria

Indexed keywords

AMPICILLIN; BETA LACTAM; SULBACTAM; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

AMPICILLIN; ANIMALS; BETA-LACTAMASES; COLONY COUNT, MICROBIAL; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MYCOBACTERIUM; PENICILLINS; PHAGOCYTOSIS; SULBACTAM;

EID: 0033212698     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00101-6     Document Type: Article

References (15)

1. Weherli W., Staehelin M. Actions of the rifamycins. Bact. Rev. 35:1971;290-309.
2. Bishai W.R., Graham N.M.H., Harrington S., Page C., Moore-Rice K., Hooper N. et al. Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. New. Eng. J. Med. 334:1996;1573-1576.
3. Jacobson R.R. Treatment. Hastings R.C. Leprosy. 1985;Churchill Livingstone, New York.
4. Desikan K.V. Relapse, reactivation or reinfection? Ind. J. Lepr. 67:1995;3-11.
5. Kasik J.E., Pecham L. Properties of β-lactamase produced by three species of mycobacteria. Biochem. J. 107:1968;675-682.
6. Prabhakaran K., Harris E.B., Randhawa B. Suppression of the growth of six potentially-pathogenic mycobacteria by β-lactam/β-lactamase-inhibitors. Microbios. 91:1997;7-14.
7. Prabhakaran K., Harris E.B., Randhawa B., Adams L.B., Williams D.L., Hastings R.C. Use of β-lactam/β-lactamase-inhibitor combinations as antimycobacterial agents. Microbios. 76:1993;251-261.
8. Randhawa B., Harris E.B., Prabhakaran K., Hastings R.C. Bactericidal action of ampicillin/ sulbactam against Mycobacterium leprae. J. Antimicrob. Chemother. 33:1994;1035-1037.
9. Wildfeuer A., Rader K. Stabilitat von β-lactamase-inhibitoren und β-lactam antibiotica inparentaralen darreichungsformen sowie in korperflussigkeiten und gewebenhomogenaten. Arneim. Forsch. 41:1991;70-73.
10. Blanchard J.S. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Ann. Rev. Biochem. 65:1996;215-235.
11. Nadler J.P., Berger J.A., Cafsky R., Saxena M. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest. 99:1991;1025-1026.
12. Chambers H.F., Kocagoz T., Sipit T., Turner J., Hopewell P.C. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin. Infect. Dis. 26:1998;874-877.
13. Randhawa B., Harris E.B., Prabhakaran K. Bactericidal action of oral ampicillin/ sulbactam against Mycobacterium leprae. J. Antimicrob. Chemother. 44:1999;279-281.
14. Ambler P. The structure of β-lactamases. Phil. Trans. R. Soc. Lond. (B). 289:1980;321-331.
15. Prabhakaran K., Harris E.B., Randhawa B., Hastings R.C. β Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a β-lactamase-stable antibiotic. Microbios. 81:1995;177-185.